Allarity Therapeutics News

Allarity Therapeutics | 8-K: Allarity Therapeutics Reports First Quarter Financial Results and Highlights, including Clear Clinical Benefits from Phase 2 Trial, NASDAQ Compliance, and Significant Improvement in Cash and Equity Balances

May 15 21:20

Allarity Therapeutics | 8-K: Current report

May 9 21:52

Allarity Therapeutics | 8-K: Current report

May 6 21:33

Allarity Therapeutics | 8-K: Current report

May 3 18:11

Allarity Therapeutics | 8-K: Current report

Apr 30 20:15

Allarity Therapeutics | 8-K: Current report

Apr 18 19:01

Allarity Therapeutics | S-1/A: General form for registration of securities under the Securities Act of 1933 (Amendment)

Apr 17 21:19

ALLARITY THERAPEUTICS INC | S-1/A: General form for registration of securities under the Securities Act of 1933 (Amendment)

Apr 9 00:38

ALLARITY THERAPEUTICS INC | 8-K: Current report

Apr 5 20:33

ALLARITY THERAPEUTICS INC | 8-K: Current report

Apr 5 05:07

ALLARITY THERAPEUTICS INC | 8-K: Current report

Apr 1 21:41

ALLARITY THERAPEUTICS INC | 8-K: Current report

Mar 26 20:09

ALLARITY THERAPEUTICS INC | S-8: Initial registration statement for securities to be offered to employees pursuant to employee benefit plans

Mar 26 04:35

ALLARITY THERAPEUTICS INC | 8-K: Current report

Mar 21 00:37

ALLARITY THERAPEUTICS INC | 8-K: Current report

Mar 15 21:15

ALLARITY THERAPEUTICS INC | 8-K: Current report

Mar 8 21:40

ALLARITY THERAPEUTICS INC | DEF 14A: Definitive information statements

Mar 8 19:05

ALLARITY THERAPEUTICS INC | 8-K: Current report

Mar 5 05:13

ALLARITY THERAPEUTICS INC | 8-K: Current report

Mar 1 22:24

ALLARITY THERAPEUTICS INC | 8-K: Current report

Feb 14 22:07